Caris Life Sciences (NASDAQ:CAI – Get Free Report) had its price target boosted by Canaccord Genuity Group from $22.00 to $30.00 in a note issued to investors on Monday, Benzinga reports. The brokerage presently has a “hold” rating on the stock. Canaccord Genuity Group’s price objective would suggest a potential downside of 1.83% from the […]

Bridgepoint Group (LON:BPT – Get Free Report) had its target price hoisted by Berenberg Bank from GBX 360 to GBX 455 in a report released on Friday, Digital Look reports. The brokerage presently has a “buy” rating on the stock. Berenberg Bank’s price target indicates a potential upside of 12.79% from the stock’s current price. […]

discoverIE Group (LON:DSCV – Get Free Report) had its target price increased by research analysts at Berenberg Bank from GBX 1,050 to GBX 1,100 in a research note issued to investors on Thursday, Digital Look reports. The firm currently has a “buy” rating on the stock. Berenberg Bank’s price target points to a potential upside […]

DexCom (NASDAQ:DXCM – Get Free Report) had its price objective hoisted by stock analysts at BTIG Research from $90.00 to $96.00 in a research report issued on Monday, Benzinga reports. The brokerage currently has a “buy” rating on the medical device company’s stock. BTIG Research’s target price suggests a potential upside of 12.86% from the […]

Mirum Pharmaceuticals (NASDAQ:MIRM – Get Free Report) had its target price increased by investment analysts at Citigroup from $160.00 to $184.00 in a report released on Monday, Benzinga reports. The firm currently has a “buy” rating on the stock. Citigroup’s price target would suggest a potential upside of 113.80% from the stock’s previous close. Other […]

Cognex (NASDAQ:CGNX – Get Free Report) had its price objective hoisted by equities researchers at Barclays from $80.00 to $85.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage currently has an “overweight” rating on the scientific and technical instruments company’s stock. Barclays‘s price target indicates a potential upside of 37.60% […]

Robinhood Markets (NASDAQ:HOOD – Get Free Report) had its price target increased by stock analysts at Morgan Stanley from $150.00 to $160.00 in a report released on Friday, Benzinga reports. The firm presently has an “overweight” rating on the stock. Morgan Stanley’s target price points to a potential upside of 49.52% from the company’s current […]

e.l.f. Beauty (NYSE:ELF – Get Free Report) had its price objective boosted by research analysts at Robert W. Baird from $105.00 to $120.00 in a research note issued on Wednesday, MarketBeat.com reports. The firm currently has an “outperform” rating on the stock. Robert W. Baird’s price objective would indicate a potential upside of 13.24% from […]

Sandisk (NASDAQ:SNDK – Get Free Report) had its price target raised by research analysts at Mizuho from $1,875.00 to $2,050.00 in a report released on Tuesday, Marketbeat Ratings reports. The firm presently has an “outperform” rating on the data storage provider’s stock. Mizuho’s price objective would suggest a potential upside of 21.13% from the stock’s […]

Zeta Global (NYSE:ZETA – Get Free Report) had its price objective raised by equities research analysts at DA Davidson from $36.00 to $38.00 in a research note issued on Tuesday, Marketbeat.com reports. The brokerage presently has a “buy” rating on the stock. DA Davidson’s target price would indicate a potential upside of 12.49% from the […]

Intel (NASDAQ:INTC – Get Free Report) had its target price lifted by analysts at Mizuho from $92.00 to $114.00 in a research report issued to clients and investors on Tuesday, MarketBeat.com reports. The brokerage presently has a “neutral” rating on the chip maker’s stock. Mizuho’s target price indicates a potential upside of 0.83% from the […]

AMETEK (NYSE:AME – Get Free Report) had its target price hoisted by analysts at Robert W. Baird from $275.00 to $280.00 in a research note issued on Monday, Benzinga reports. The firm currently has a “neutral” rating on the technology company’s stock. Robert W. Baird’s price objective would suggest a potential upside of 10.37% from […]